Pang_2023_Physiol.Behav_263_114134

Reference

Title : The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation - Pang_2023_Physiol.Behav_263_114134
Author(s) : Pang B , Zhang LL , Li B , Sun FX , Wang ZD
Ref : Physiol Behav , 263 :114134 , 2023
Abstract : Pang_2023_Physiol.Behav_263_114134
ESTHER : Pang_2023_Physiol.Behav_263_114134
PubMedSearch : Pang_2023_Physiol.Behav_263_114134
PubMedID: 36809844

Related information

Citations formats

Pang B, Zhang LL, Li B, Sun FX, Wang ZD (2023)
The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation
Physiol Behav 263 :114134

Pang B, Zhang LL, Li B, Sun FX, Wang ZD (2023)
Physiol Behav 263 :114134